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Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors that originate from interstitial cells of Cajal or their
stem cell-like precursors. Generally, GISTs have specific c-KIT gene mutations. The incidence of GISTs is estimated to
be 10 to 20 cases/one million individuals, and GISTs typically affect people over 50 years of age. The majority of
GISTs are solitary. However, multifocal GISTs have been observed, especially in children. We report on two unusual
adult cases of double GISTs that were treated by laparoscopic surgery. The first patient presented a polypoid mass
of the fundus and a second isolated smaller tumor in the posterior wall of the lesser curvature of the stomach. A
histopathological examination confirmed that both tumors were GISTs and were c-KIT-positive. A total laparoscopic
gastrectomy was performed. In the second patient, GISTs were identified at the level of the fundus and the greater
curvature of the stomach. A laparoscopic partial sleeve gastrectomy was performed. Both surgeries were successful
with no complications or relapses at three to five years following surgery.
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Gastrointestinal stromal tumors (GISTs) are mesenchy-
mal neoplasms of the gastrointestinal tract that account
for approximately 0.1% to 3% of all gastrointestinal ma-
lignancies [1]. GISTs occur more frequently in the stom-
ach (60% to 70%), followed by the small intestine (20%
to 30%), the colon and the rectum (5%), and the esopha-
gus (less than 5%) [1,2].
In most cases, GISTs originate from interstitial cells of
Cajal, a complex cellular network that regulates gastro-
intestinal motility, or mesenchymal stem cells of the
mesentery or omentum, which transform into the malig-
nant phenotype that expresses the proto-oncogene c-Kit
(CD 117) and less frequently the platelet-derived growth
factor receptor-α (PDGFRA) [3,4].
Small GISTs (less than 2 cm in diameter) are usually
asymptomatic and are detected during investigations per-
formed for other unrelated diseases. Conversely, GISTs* Correspondence: nic.deangelis@yahoo.it
1Digestive and Liver Transplant Surgery Unit, Henri-Mondor Hospital,
Université Paris Est, 51 avenue du Maréchal de Lattre de Tassigny, 94010
Créteil, France
Full list of author information is available at the end of the article
© 2014 de’Angelis et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumthat are greater than 2 cm are generally associated with
clinical signs and symptoms, such as nausea, vomiting, ab-
dominal pain, obstruction, abdominal mass, anemia and
melena [2,3]. Diagnosis and staging are usually based on
abdominal ultrasonography, computed tomography (CT)
scanning, and/or magnetic resonance imaging (MRI).
Clinically, GISTs vary from virtually benign diseases to
aggressive tumors (20% to 30% of cases) with a five-year
survival rate that ranges from 35% to 65% depending on
the tumor size, the mitotic index (the mitotic count/50
high-power fields, HPFs) and the tumor location [5].
Moreover, 50% of GISTs may be metastatic at presenta-
tion, and the most common sites of metastases are the
peritoneum and the liver [1,3,6]. Over 95% of primary
GISTs are solitary tumors; however, case reports and
small case series have reported multiple primary lesions,
which were restricted to the familial or pediatric forms,
and district syndromes (type 1 neurofibromatosis, von
Recklinghausen disease and Carney’s syndrome) [1,3,7].
Complete surgical resection is the only curative treat-
ment for GISTs [8]. However, the recent introduction of
specific pathogenesis-targeted treatments with a Kit tyro-
sine kinase inhibitor, imatinib mesylate (Glivec®, Novartistral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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provements in non-resectable patients (a palliative cure),
and it has been successfully used as adjuvant therapy for
tumors with a high risk of relapse [4].
Case Presentation
We report two unusual cases of double GISTs of the
stomach in two female adult patients.
Case report 1
A 59-year-old female patient with a history of hyperten-
sion, breast cancer and type II diabetes visited her gen-
eral practitioner because of a stomachache, dysphagia to
solids, weight loss (approximately 13 kg), and general fa-
tigue that began three months earlier. She was referred
to a gastroenterologist for further examinations. An eso-
phagogastroscopy was performed and indicated chronic
gastritis of the antrum and a polypoid lesion of the fun-
dus, which was suggestive of a GIST (Figure 1a). A CT
scan was performed for diagnosis and staging. The CT
showed a tumoral mass under the cardia region that was
8 × 7 × 6 cm without sites of distant metastasis (Figure 1b).
Echoendoscopy with fine needle aspiration (EUS-FNA)Figure 1 Imaging and schematic representation of double GIST in cas
of the fundus, which was suggestive of a GIST. b. Case report 1. CT scan im
without sites of distant metastasis. c. Case report 1. Echoendoscopy with fi
tumor. d. Case report 1. A schematic representation of the locations of the
polypoid lesion on the fundus of the stomach. Tumor 2 was discovered int
of the lesser curvature.confirmed the presence of the mass (Figure 1c), but an im-
munohistochemical examination was not specific for a
GIST. The serological tumoral biomarkers (CA 15.3, CA
125, CEA and CA 19.9) were negative.
The patient planned to undergo laparoscopic surgery
for the resection of the tumor by sleeve gastrectomy.
However, the intra-operative laparoscopic ultrasound
uncovered another lesion that was isolated from the
mass of the fundus and located in the posterior wall of
the lesser curvature of the stomach (Figure 1d). There-
fore, for anatomical reasons, the planned surgical tech-
nique was changed, and a total laparoscopic gastrectomy
with Roux-en-Y reconstruction was performed for the
resection of both tumors.
The histopathological and immunohistochemical ex-
aminations revealed two isolated GISTs (7 × 6 × 6 cm
and 2.5 × 1 × 1 cm) that were c-kit- and CD34-positive
and SMMA- and PDGFRA-negative. A mutation in the
11th exon of the KIT gene was observed in only one le-
sion. In the first tumor, two to four mitoses per 50 HPF
were counted, and five mitoses per 50 HPF were found
in the second tumor. The resection margins (R0) and
the lymph nodes were free of neoplasia (0/34). Thee report 1. a. Case report 1. Esophagogastroscopy: a polypoid lesion
aging: a tumoral mass under the cardia region was 8 × 7 × 6 cm
ne needle aspiration (EUS-FNA) imaging. Visualization of the gastric
double GISTs. Tumor 1 was 7 × 6 × 6 cm and was observed to be a
ra-operatively, was 2.5 × 1 × 1 cm and was located in the posterior wall
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was discharged on the 14th postoperative day. Adjuvant
therapy was proposed with Glivec® 400 mg/day for
12 months. After five years of follow-up, the patient is
clinically and radiographically disease-free.
Case report 2
A 62-year-old female patient visited her general practi-
tioner because of a stomachache, chronic diarrhea, occa-
sional melena and weight loss (approximately 7 kg). An
esophagogastroscopy was performed and revealed a polyp-
oid lesion of the fundus, which was suggestive of a GIST. A
CT scan was performed for diagnosis and staging. The CT
confirmed the intramural lesion at the level of the fundus
of the stomach (6 × 5 × 2.5 cm) and showed another extra-
luminal gastric mass that was located in the middle of the
greater curvature (2.5 × 1.5 × 1 cm) (Figure 2a,b). No sitesa
b
Figure 2 Imaging and schematic representation of double GIST
in case report 2. a. Case Report 2. CT scan imaging: the tumoral
lesions (the red arrows) were 6 × 5 × 2.5 cm and 2.5 × 1.5 × 1 cm.
b. Case report 2. A schematic representation of the location of the
double GISTs. Tumor 1 was an intramural lesion at the level of the
fundus of the stomach (6 × 5 × 2.5 cm), whereas tumor 2 was an
extraluminal gastric mass located in the middle of the greater
curvature (2.5 × 1.5 × 1 cm).of distant metastasis were observed. EUS-FNA was per-
formed on both tumors. The immunohistochemical exami-
nations were specific for double GISTs.
The patient underwent laparoscopic resection by par-
tial sleeve gastrectomy.
The histopathological and immunohistochemical ex-
aminations revealed two isolated GISTs (5.5 × 5 × 2.5 cm
and 2 × 1 × 1 cm) that were c-kit- and CD34-positive and
SMMA-negative. Mutations in the 9th and 11th exons of
the KIT gene were observed in the first tumor, whereas a
mutation in the 9th exon of the KIT gene was present in
the second tumor. In the first tumor, three mitoses per
50 HPF were counted, and two mitoses per 50 HPF were
found in the second tumor. The resection margins (R0)
were free of neoplasia. The postoperative course was un-
eventful, and the patient was discharged on the sixth
postoperative day. Adjuvant therapy was proposed with
Glivec® 400 mg/day for 12 months. After three years of
follow-up, the patient is clinically and radiographically
disease-free.
Discussion
GISTs are rare neoplasms of the gastrointestinal tract,
which occur mostly as solitary tumors [1,6]. We report
two unusual cases of double synchronous lesions that
we observed among our series of 48 consecutive gastric
resections for GISTs from 2005 to 2013. To our know-
ledge, this is the only case report in the literature of
double gastric GISTs in adult patients after the one pub-
lished by Golabek-Dropiewska and coworkers in 2009 [7].
Both our case patients had no history of familial GISTs,
no diagnoses of GIST-related district syndromes, or any
signs of metastatic spreading from a single primary GIST.
Moreover, the patterns that were detected in the histo-
pathological and immunohistochemical analyses supported
the diagnosis of double sporadic GISTs. Particularly, the
synchronous location in the proximal stomach, the close
proximity and the demonstration of different kit mutations
in the individual lesions suggested the presence of distinct
subsets of gastric GISTs of an unknown etiology. As re-
ported in the literature, the majority (approximately 79%)
of cases of multifocal and closely associated GISTs that
present c-kit+ and CD34+ phenotypes are initiated by dif-
ferent types of somatic KIT exon 9 and 11 mutations
[9-11]. In the case of multiple mutations, they may be pri-
mary or, more frequently, acquired secondary mutations,
which occur independently and randomly in individual
GIST cells.
Surgical treatment is indicated in the case of a non-
metastatic GIST >2 cm, and the standard primary treat-
ment is complete resection with recommended 1-cm
negative margins without tumor rupture. Microscopic
negative margins are sufficient to ensure R0 resection
[6,8,12]. The laparoscopic approach can be safely used
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application is limited by the location and the size of the
tumor [13].
Radiographic assessment is a prerequisite for correct
surgical planning. In the initial investigation, esophago-
gastroscopy and trans-abdominal ultrasonography are
undertaken. Then, in patients with gastric resectable
GISTs, EUS-FNA and a CT scan with a “stomach proto-
col” [14] are performed to study the local anatomy and
the histopathological analysis and to rule out the presence
of metastatic spread. A CT scanner may have limitations
in the assessment of small GISTs, whereas it has greater
specificity and sensitivity for larger GISTs [15]. In case of
an allergy to contrast media or for questions regarding
liver metastases, MRI is useful to determine the relation-
ship between the tumor and the adjacent organs [16].
In Case Report 1, we performed different diagnostic
imaging techniques; however, only the larger GIST was
correctly detected. Most likely due to its small size, the
second GIST was not identified even by EUS-FNA. Dur-
ing surgery, we performed intra-operative laparoscopic
ultrasound to evaluate the relationship between the
tumor and the cardias. This procedure indicated the
presence of another small lesion in the posterior wall
close to the cardias. The discovery of a second tumor
and the proximal location (<1 cm) from the gastro-
esophageal (GE) junction required a total laparoscopic
gastrectomy to guarantee an en-block excision with R0
resection margins and prevent stenosis of the GE junc-
tion. Moreover, we performed an extensive lymphadenec-
tomy, even though this procedure is not recommended,
because we did not know peri-operatively the nature of
the second tumor. In this patient, the anatomical charac-
teristics of the double GISTs determined the surgical
choice, which led to a more invasive surgery that was
counterbalanced by the achievement of the oncological
outcomes.
In Case Report 2, the correct detection of both GISTs
pre-operatively and their location at the greater curva-
ture allowed us to perform a laparoscopic sleeve gastrec-
tomy, which is less invasive and associated with a
shorter recovery.
In both patients, the laparoscopic approach was se-
lected regardless of the tumor size and the tumor loca-
tion. The patient positioning and the location of the
trocars were similar to those used in laparoscopic sur-
geries for early gastric cancers and Toupet fundoplica-
tion. The location of the trocars was adjusted to the left
and proximally for lesions of the fundus of the stomach
and distally when lesions were located toward the an-
trum. Before initiating the resection, we systematically
performed an intra-operative laparoscopic ultrasound to
better locate small lesions. If needed, intra-operative en-
doscopy can be used to support the surgical excision.Conclusion
In conclusion, this case report presents the surgical
treatment of two unusual double gastric GISTs in adult
patients. The laparoscopic approach was confirmed as a
safe and effective technique, regardless of the size and
the location of the tumor, when performed by skilled
surgeons who work in a high-volume center.
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